pSivida Corp

Press Releases

All Releases
View Summary pSivida Corp Announces Fourth Quarter and Fiscal Year 2014 Financial Results Release Date and Conference Call Information
Sep 3, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Sweden, 10th EU Approval
Sep 3, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Denmark, 9th EU Approval
Jul 31, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal
Jul 28, 2014
PDF 16.7 KB Add to Briefcase
View Summary pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for Marketing Authorizations in 10 More EU Countries
Jun 30, 2014
PDF 17.2 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® Receives Marketing Authorization in Italy for Treatment of Chronic Diabetic Macular Edema
Jun 23, 2014
PDF 15.8 KB Add to Briefcase
View Summary pSivida Corp. Reports Third Quarter 2014 Results
May 13, 2014
PDF 29.9 KB Add to Briefcase
View Summary pSivida Presents Preclinical Data Demonstrating Sustained Release of Avastin Using Tethadur at ARVO Annual Meeting
May 5, 2014
PDF 16.3 KB Add to Briefcase
View Summary pSivida Corp Announces Third Quarter 2014 Financial Results Release Date and Conference Call Information
May 2, 2014
PDF 16.6 KB Add to Briefcase
View Summary pSivida Reports Australia/New Zealand Distribution Agreement for ILUVIEN® for DME
Apr 28, 2014
PDF 16.2 KB Add to Briefcase
View Summary pSivida Selected to Present at 2014 Opthalmology Innovation Summit
Apr 23, 2014
PDF 17.0 KB Add to Briefcase
View Summary pSivida Announces September 26, 2014 PDUFA Date for ILUVIEN®
Apr 14, 2014
PDF 15.9 KB Add to Briefcase
View Summary pSivida CEO to Discuss Company's Sustained Release Delivery System for Biologics at Two Upcoming Conferences
Apr 1, 2014
PDF 17.0 KB Add to Briefcase
View Summary pSivida Announces Resubmission of New Drug Application for ILUVIEN®
Mar 27, 2014
PDF 16.1 KB Add to Briefcase
View Summary pSivida Corp. Announces $7.0 Million Investment by RA Capital
Mar 13, 2014
PDF 14.0 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® for DME Accepted by National Health Service Scotland
Feb 10, 2014
PDF 16.5 KB Add to Briefcase
View Summary pSivida Corp. Reports Second Quarter 2014 Results
Feb 7, 2014
PDF 29.9 KB Add to Briefcase
View Summary pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 11
Feb 6, 2014
PDF 17.3 KB Add to Briefcase
View Summary pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 12
Feb 6, 2014
PDF 17.3 KB Add to Briefcase
View Summary pSivida Corp Announces Second Quarter 2014 Financial Results Release Date and Conference Call Information
Jan 30, 2014
PDF 16.9 KB Add to Briefcase
Showing 81-100 of 278 Page: 1 2 3 4 5 6 7 8 9 ... 14  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida